OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	71
Improving Medication Adherence in Asthma	68
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	47
Sleep, Circadian Rhythms, and Lung Cancer	46
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	45
Nonmalignant Pleural Effusions	40
Mechanical Ventilation for COVID-19 Patients	38
Severe Infections Due to Respiratory Viruses	37
	35
Impact of Marijuana Use on Lung Health	31
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	23
Lung Transplant for Chronic Obstructive Pulmonary Disease	22
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	20
Prevention of Aspiration: Oral Care, Antibiotics, Others	20
Indwelling Pleural Catheter: Management of Complications	19
Imaging in the Intensive Care Unit	17
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection	17
Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function.	16
Antibiotic Strategies for Severe Community-Acquired Pneumonia	16
	16
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	15
Deployment-Related Respiratory Disease: Where Are We?	15
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	15
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	14
Management of Dyspnea in Patients with Neuromuscular Disorders	14

COVID-19-Related Pleural Diseases	14
	13
Pulmonary Physiology and Medicine of Diving	12
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	12
Update on Sepsis Epidemiology in the Era of COVID-19	12
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia	12
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	12
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	11
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	11
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes	10
Bronchoscopic Lung Volume Reduction: A Review	10
How to Survive Sepsis: Patient Testimonial	10
Understanding the Updates in the Asthma Guidelines	10
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	10
Survivorship Challenges and Supportive Care in Lung Cancer	10
Any Role of High-Dose Vitamin C for Septic Shock in 2021?	10
Definition and Epidemiology of Sepsis	10
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	10
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	9
Emerging Concepts in Fibroblast Biology and Progressive Pulmonary Fibrosis	9
Evidence for the Application of Sepsis Bundles in 2021	9
Work-Related Sleep Disorders: Causes and Impacts	9
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients	9
Lung Cancer in Special Populations	9
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	8
Management of Acutely Decompensated Pulmonary Hypertension	8
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	8
Malignant Central Airway Obstruction: What's New?	8
Interstitial Lung Disease Associated with Systemic Sclerosis	8
Pertussis Vaccination: The Challenges Ahead	7
Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice	7
Peeling Back the Layers of the Bleomycin Model of Lung Fibrosis: Lessons Learned, Factors to Consider, and Future Directions	7
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	7
Arterial Blood Gases and Acid–Base Regulation	7
Intra-abdominal Infections	7
Life-Threatening Infections: Pulmonary and Systemic Infections	7
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia	7
Pathological Diagnosis of Pulmonary Aspergillosis	7
Aspergillus and the Lung	7
	7
Severe Community-Acquired Pneumonia	7
Severe Community-Acquired Pneumonia in Immunocompromised Patients	7
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy	6
Use of Antiviral Agents and other Therapies for COVID-19	6
Pulmonary Hypertension Associated with Left Heart Disease	6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests	6
Sleep and Circadian-Related Outcomes after Critical Illness	6
Aspiration Pneumonia: Preface	6
Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure	6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia	6

Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement	6
“Long Haulers”	6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias	6
HIV and COVID-19 Disease	6
Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?	6
Control of Breathing	6